| Literature DB >> 33789741 |
Nsofwa Sukwa1, Michelo Simuyandi2, Masuzyo Chirwa1, Yvonne Mutombo Kumwimba1, Obvious N Chilyabanyama1, Natasha Laban1, Aybüke Koyuncu1, Roma Chilengi1.
Abstract
BACKGROUND: Despite an otherwise robust national antenatal clinic program, maternal and congenital syphilis remains an important public health issue in Zambia. This case series reports the clinical presentation of seven infants diagnosed with congenital syphilis in Lusaka, Zambia. CASE PRESENTATIONS: The cases in this series were incidental findings from a cohort of infants enrolled in a rotavirus vaccine immunogenicity study recruiting infants at 6 weeks of age. As part of clinical care for enrolled participants, we screened mothers of children who presented with adverse events of (i) repeated upper respiratory tract infections/coryza, (ii) skin lesions, and (iii) poor weight gain, for syphilis using rapid plasma reagin test. From a cohort of 214 mother-infant pairs enrolled between September and December 2018, a total of 115 (44.4%) of the mothers reported to have not been screened during antenatal care. Of these, four (3.5%) reported to have tested positive; and only two received treatment. Seven out of 57 (26.6%) children meeting the screening criteria had a positive rapid plasma reagin test result. The mean age at diagnosis was 4.5 months (1.3 months standard deviation), and the common presenting features included coryza (6/7), skin lesions (4/7), conjunctivitis (3/7), pallor/anemia (5/7), wasting (2/7), and underweight (5/7). Three of the seven infants were exposed to human immunodeficiency virus. Following diagnosis, all seven cases received standard treatment according to national treatment guidelines. That is, 6/7 cases received inpatient care with benzylpenicillin for 10 days, while 1/7 was treated as an outpatient and received daily procaine penicillin for 10 days.Entities:
Keywords: Case report; Congenital syphilis; Infants; Infection; Syphilis; Zambia
Year: 2021 PMID: 33789741 PMCID: PMC8015191 DOI: 10.1186/s13256-021-02745-1
Source DB: PubMed Journal: J Med Case Rep ISSN: 1752-1947
Fig. 1Study flow chart
Summary of clinical characteristics of the seven cases
| Clinical characteristics | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 |
|---|---|---|---|---|---|---|---|
| Coryza/URTI | + | + | + | + | − | + | + |
| Skin lesion | + | + | + | − | + | − | − |
| Conjunctivitis | + | − | − | + | − | + | − |
| Musculoskeletal deformities | − | − | − | − | − | − | − |
| Vaginal discharge | + | N/A | N/A | N/A | − | − | NA |
| Hepatomegaly | − | − | + | − | − | − | − |
| Preterm birth | + | − | − | − | − | − | − |
| Anemia/pallor | + | + | + | − | + | - | + |
+, present; −, absent; N/A, not applicable; URTI, upper respiratory tract infection
Summary of clinical and laboratory investigations done
| Characteristic | Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | Case 7 | Mean (SD) |
|---|---|---|---|---|---|---|---|---|
| Age at presentation (days) | 4 | 5 | 42 | 120 | 28 | 105 | 60 | Median (IQR) 42 (5–105) |
| Age at diagnosis (months) | 5 | 5.5 | 6 | 5 | 4 | 4 | 2 | 4.5 (1.3) |
| Presenting symptoms | Conjunctivitis | RTI | Coryza | RTI | Dermatitis | Coryza | Coryza | |
| Birth weight (kg) | 3.2 | 2.2 | 3.5 | 3.7 | 3.4 | 3.6 | 2.9 | 3.2 (0.5) |
| Mother screened at antenatal care | No | No | No | Yes (NR) | No | No | No | |
| HIV status | CNE | CE | CNE | CNE | CE | CNE | CE | |
| Weight at diagnosis (kg) | 5.4 | 6.3 | 6.4 | 6.8 | 4.6 | 5.6 | 3.8 | 5.6 (1.1) |
| Length at diagnosis (cm) | 64 | 63 | 64 | 67 | 58.5 | 64 | 53 | 61.9 (4.7) |
| Weight for length | −3 < −2 | −2 < −1 | −2 < −1 | −2 < −1 | −2 | −3 < −2 | −1 < Med | |
| Wt for age | −2 SD | −2 SD < −1 SD | −2 SD | −1 < Median | −3 < −2 | −3 < −2 | −3 | |
| TPHA titers (1:8) | 1:4 | – | 1:32 | – | – | – | – | |
| FBC | ||||||||
| Hemoglobin (10.5–14 g/dL) | 7.0 | 7.1 | 10.2 | 9.1 | 8.2 | 8.3 (1.4) | ||
| MCV (72–88 fL) | 59.7 | 71.9 | 66.7 | 72.9 | 85.3 | 71.3 (9.4) | ||
| MCH (24–30 pg) | 17.2 | 18.2 | 21.3 | 22.9 | 26.2 | 21.2 (3.6) | ||
| WCC (6–14 × 103/μL) | 15 | 10.4 | 17 | 14 | 16.79 | 14.6 (2.7) | ||
| Platelets (150–450 × 103/μL) | 300 | 594 | 657 | 344 | 255 | 430 (182.6) | ||
| Differential count | ||||||||
| Neutrophils (16–52%) | 31 | 15 | 23 | 16 | 27.4 | 22.5 (7) | ||
| Lymphocytes (32–69%) | 64 | 72 | 71 | 79 | 55.8 | 68.4 (8.8) | ||
| Monocytes (2–8%) | 2 | 11 | 4 | 3 | 16.2 | 7.2 (6.1) | ||
| Eosinophils (0–5%) | 3 | 1 | 2 | 2 | 0.4 | 1.7 (1) | ||
| Basophils (0–2%) | 0 | 1 | 0 | 0 | 0.2 | 0.2 (0.4) | ||
CNE, no perinatal HIV exposure—child not exposed; CE, perinatal HIV exposure—child exposed; NR, nonreactive; RTI, respiratory tract infection; SD, standard deviation; TPHA, Treponema pallidum hemagglutination assay